Marc Wolfgang

Marc Wolfgang is a seasoned professional in the biopharmaceutical industry, currently serving as SVP of Technical Development and Operations at Sail Biomedicines since June 2023. Previous roles include VP of Technical Operations at BioNTech US from May 2020 to May 2023 and VP of Technical Operations at Neon Therapeutics from November 2016 until its acquisition by BioNTech in May 2020. Marc also held the position of VP of Technical Operations at Cerulean Pharma Inc. for nearly a decade. Earlier in the career, Marc served in various roles at Momenta Pharmaceuticals, Millennium Pharmaceuticals, Biogen, and Boehringer Ingelheim, focusing on quality assurance and technical operations. Educational qualifications include a BS in Biology-Genetics from Penn State University and an MS in Chemistry from Montclair State University.